LUX-head and neck 2: Randomized, double-blind, placebo-controlled, phase III trial of afatinib as adjuvant therapy after chemoradiation (CRT) in primary unresected, high/intermediate-risk, squamous ...

Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...

Chemoradiation is a combination of chemotherapy drugs and radiation therapy. It’s usually not used for all types of cancers, but research shows it can be an effective treatment option for anal ...

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds. The results ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made ...

The first UKCCCR Anal Cancer Trial (1996) demonstrated the benefit of chemoradiation over radiotherapy (RT) alone for treating epidermoid anal cancer, and it became the standard treatment.

Conclusions: Chemoradiation combined with immunotherapy as an adjuvant therapy demonstrated superior survival outcomes over observation in resectable ECC/GBC patients with a well-tolerable safety ...

A long course of chemoradiation therapy appeared associated with higher organ preservation rates vs. a short course among a cohort of patients with rectal cancer, according to a study presented at ...

In this study, Dr. Yom and her team tested two lower-intensity treatment regimens against a control arm of more standard chemoradiation for people with HPV-associated, locoregionally advanced ...

Patients with locally advanced rectal cancer who underwent treatment with fluorouracil, leucovorin and oxaliplatin — a combination referred to as FOLFOX — before sphincter-sparing surgery had similar ...

Existing standard chemoradiation superior to deintensification approaches for HPV-related oropharyngeal cancer Randomized trial halted after two deintensification strategies failed to match ...

Hypofractionated concurrent chemoradiation (cCRT) at doses higher than usual followed by an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising safety and efficacy in ...